| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 20 | 2023 | 1797 | 2.080 |
Why?
|
| Software | 6 | 2021 | 1321 | 1.030 |
Why?
|
| Genomics | 12 | 2023 | 2738 | 1.010 |
Why?
|
| Glioma | 11 | 2023 | 1963 | 1.010 |
Why?
|
| Neoplasms | 13 | 2023 | 15193 | 0.930 |
Why?
|
| Brain Neoplasms | 18 | 2023 | 4849 | 0.920 |
Why?
|
| Chromosome Breakage | 2 | 2013 | 226 | 0.890 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2021 | 8873 | 0.780 |
Why?
|
| Telomerase | 2 | 2021 | 525 | 0.640 |
Why?
|
| Genome, Human | 6 | 2021 | 1869 | 0.580 |
Why?
|
| Oncogenes | 3 | 2022 | 673 | 0.580 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 2016 | 223 | 0.570 |
Why?
|
| Computational Biology | 3 | 2021 | 1271 | 0.560 |
Why?
|
| Mutation | 19 | 2023 | 15179 | 0.560 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2021 | 755 | 0.560 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 651 | 0.540 |
Why?
|
| Xenograft Model Antitumor Assays | 12 | 2023 | 3821 | 0.520 |
Why?
|
| Benchmarking | 1 | 2017 | 273 | 0.520 |
Why?
|
| Research Design | 2 | 2022 | 1544 | 0.520 |
Why?
|
| Isocitrate Dehydrogenase | 8 | 2022 | 480 | 0.500 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2016 | 172 | 0.470 |
Why?
|
| RNA Splice Sites | 1 | 2014 | 111 | 0.470 |
Why?
|
| Statistics as Topic | 1 | 2014 | 445 | 0.430 |
Why?
|
| Transcriptome | 8 | 2024 | 1859 | 0.430 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 2291 | 0.420 |
Why?
|
| Protein Interaction Mapping | 2 | 2010 | 162 | 0.400 |
Why?
|
| Heterografts | 3 | 2023 | 733 | 0.390 |
Why?
|
| Gene Fusion | 3 | 2018 | 209 | 0.350 |
Why?
|
| Single-Cell Analysis | 3 | 2022 | 470 | 0.350 |
Why?
|
| Prognosis | 7 | 2022 | 21713 | 0.340 |
Why?
|
| Datasets as Topic | 2 | 2021 | 181 | 0.330 |
Why?
|
| Cell Line, Tumor | 18 | 2023 | 14551 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2017 | 143 | 0.300 |
Why?
|
| DNA Copy Number Variations | 7 | 2021 | 1516 | 0.300 |
Why?
|
| Animals | 28 | 2024 | 59536 | 0.290 |
Why?
|
| Databases, Genetic | 3 | 2021 | 745 | 0.290 |
Why?
|
| Humans | 51 | 2024 | 261506 | 0.270 |
Why?
|
| Antineoplastic Agents | 6 | 2021 | 14289 | 0.260 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 1443 | 0.260 |
Why?
|
| Disease Models, Animal | 7 | 2023 | 7222 | 0.250 |
Why?
|
| Gene Expression Profiling | 9 | 2024 | 5159 | 0.250 |
Why?
|
| Genetic Therapy | 1 | 2012 | 1616 | 0.240 |
Why?
|
| Mice, Nude | 10 | 2021 | 4307 | 0.220 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 2 | 2020 | 27 | 0.210 |
Why?
|
| Signal Transduction | 11 | 2023 | 11965 | 0.210 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 2 | 2020 | 68 | 0.210 |
Why?
|
| Phagocytosis | 1 | 2023 | 260 | 0.210 |
Why?
|
| Mice | 20 | 2023 | 34495 | 0.210 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2021 | 65 | 0.200 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2022 | 176 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2020 | 810 | 0.200 |
Why?
|
| Carcinogenesis | 4 | 2024 | 1026 | 0.200 |
Why?
|
| Snail Family Transcription Factors | 1 | 2021 | 120 | 0.200 |
Why?
|
| Child | 6 | 2023 | 29154 | 0.200 |
Why?
|
| Cell Proliferation | 8 | 2023 | 7226 | 0.200 |
Why?
|
| Survival Analysis | 6 | 2021 | 9180 | 0.200 |
Why?
|
| Enzyme Assays | 1 | 2021 | 22 | 0.200 |
Why?
|
| Neovascularization, Physiologic | 1 | 2023 | 345 | 0.190 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 1910 | 0.190 |
Why?
|
| Rhabdomyosarcoma | 2 | 2021 | 341 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2023 | 5178 | 0.190 |
Why?
|
| Radiation, Ionizing | 1 | 2021 | 187 | 0.190 |
Why?
|
| Neoplasm Grading | 4 | 2019 | 1742 | 0.190 |
Why?
|
| Clonal Evolution | 2 | 2020 | 253 | 0.190 |
Why?
|
| Telomere Homeostasis | 1 | 2021 | 73 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 2054 | 0.180 |
Why?
|
| Data Mining | 1 | 2021 | 88 | 0.180 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2020 | 45 | 0.180 |
Why?
|
| Proteins | 1 | 2008 | 1963 | 0.180 |
Why?
|
| Genome | 1 | 2013 | 672 | 0.180 |
Why?
|
| Neurofibromin 1 | 1 | 2019 | 85 | 0.170 |
Why?
|
| Genomic Instability | 2 | 2013 | 519 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2017 | 327 | 0.170 |
Why?
|
| Macrophages | 2 | 2023 | 1304 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 1 | 2019 | 201 | 0.160 |
Why?
|
| Cell Cycle | 2 | 2021 | 2084 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 3101 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2020 | 986 | 0.160 |
Why?
|
| Phthalazines | 1 | 2019 | 253 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 333 | 0.150 |
Why?
|
| Gene Rearrangement | 2 | 2013 | 783 | 0.150 |
Why?
|
| Gene Amplification | 1 | 2019 | 731 | 0.140 |
Why?
|
| Biomarkers, Tumor | 5 | 2021 | 10331 | 0.140 |
Why?
|
| Transcription, Genetic | 3 | 2021 | 3154 | 0.140 |
Why?
|
| DNA Damage | 3 | 2020 | 1954 | 0.140 |
Why?
|
| Endosomes | 1 | 2016 | 109 | 0.140 |
Why?
|
| Internet | 1 | 2021 | 706 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 834 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2019 | 3552 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 1070 | 0.130 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 424 | 0.130 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 88 | 0.130 |
Why?
|
| DNA Methylation | 5 | 2017 | 2669 | 0.130 |
Why?
|
| Aged | 10 | 2022 | 70117 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2015 | 64 | 0.130 |
Why?
|
| Neuroblastoma | 2 | 2019 | 686 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 181 | 0.130 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2015 | 142 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 502 | 0.130 |
Why?
|
| Pseudogenes | 1 | 2014 | 81 | 0.120 |
Why?
|
| Lysosomes | 1 | 2016 | 347 | 0.120 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 28 | 0.120 |
Why?
|
| Gene Expression | 5 | 2018 | 3570 | 0.120 |
Why?
|
| Adenine | 1 | 2017 | 631 | 0.120 |
Why?
|
| Young Adult | 4 | 2022 | 21445 | 0.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 99 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1129 | 0.110 |
Why?
|
| Transcription Factors | 3 | 2017 | 5270 | 0.110 |
Why?
|
| Gene Regulatory Networks | 5 | 2021 | 677 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2018 | 540 | 0.110 |
Why?
|
| Lymphoma, B-Cell | 1 | 2020 | 895 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 1724 | 0.110 |
Why?
|
| Autoantigens | 1 | 2014 | 234 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 2045 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2013 | 198 | 0.110 |
Why?
|
| User-Computer Interface | 2 | 2018 | 286 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 419 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2017 | 6150 | 0.110 |
Why?
|
| beta Catenin | 1 | 2016 | 688 | 0.100 |
Why?
|
| Cluster Analysis | 4 | 2016 | 1053 | 0.100 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 493 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 493 | 0.100 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 3343 | 0.100 |
Why?
|
| Adolescent | 4 | 2022 | 31252 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2011 | 153 | 0.100 |
Why?
|
| Female | 18 | 2021 | 141928 | 0.100 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 2864 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2021 | 1869 | 0.100 |
Why?
|
| Genes, p53 | 1 | 2015 | 1090 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 984 | 0.100 |
Why?
|
| Middle Aged | 11 | 2019 | 86204 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2014 | 383 | 0.090 |
Why?
|
| Adult | 10 | 2019 | 77950 | 0.090 |
Why?
|
| Male | 14 | 2020 | 123000 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 621 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2018 | 1756 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 2508 | 0.090 |
Why?
|
| Chromatin | 2 | 2017 | 942 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 507 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2018 | 4549 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 3 | 2024 | 5061 | 0.090 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2011 | 363 | 0.090 |
Why?
|
| Algorithms | 1 | 2021 | 3890 | 0.090 |
Why?
|
| Exome | 1 | 2015 | 1239 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2017 | 2086 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 630 | 0.080 |
Why?
|
| Cisplatin | 2 | 2015 | 2432 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2008 | 100 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 365 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 1143 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 5112 | 0.080 |
Why?
|
| Piperazines | 1 | 2017 | 2101 | 0.080 |
Why?
|
| Base Sequence | 1 | 2014 | 4917 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 1265 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 4821 | 0.070 |
Why?
|
| Whole Genome Sequencing | 2 | 2020 | 338 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2019 | 4757 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 1439 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 29902 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 2796 | 0.070 |
Why?
|
| Proteolysis | 2 | 2018 | 370 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 838 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2013 | 2022 | 0.060 |
Why?
|
| Cell Movement | 2 | 2023 | 2466 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 10001 | 0.060 |
Why?
|
| Acinar Cells | 1 | 2024 | 53 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2011 | 1818 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2578 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3230 | 0.060 |
Why?
|
| Histones | 1 | 2010 | 1466 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 5395 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 10035 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2020 | 1678 | 0.060 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2023 | 164 | 0.050 |
Why?
|
| Galactose | 1 | 2022 | 87 | 0.050 |
Why?
|
| B7 Antigens | 1 | 2023 | 84 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 5539 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 2265 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 6009 | 0.050 |
Why?
|
| Histone Demethylases | 1 | 2023 | 144 | 0.050 |
Why?
|
| Apoptosis | 4 | 2021 | 7591 | 0.050 |
Why?
|
| Lysine | 1 | 2023 | 422 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2023 | 316 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 368 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 6942 | 0.050 |
Why?
|
| Microarray Analysis | 2 | 2011 | 392 | 0.050 |
Why?
|
| DNA Repair | 2 | 2023 | 1872 | 0.050 |
Why?
|
| Recurrence | 2 | 2019 | 4758 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 443 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2023 | 588 | 0.040 |
Why?
|
| Protein Binding | 2 | 2018 | 3438 | 0.040 |
Why?
|
| Receptor, TIE-2 | 1 | 2019 | 82 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 222 | 0.040 |
Why?
|
| CDC2 Protein Kinase | 1 | 2019 | 176 | 0.040 |
Why?
|
| Phenotype | 2 | 2023 | 6295 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2018 | 4804 | 0.040 |
Why?
|
| RNA Interference | 2 | 2015 | 1408 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2017 | 3536 | 0.040 |
Why?
|
| Karyotyping | 1 | 2020 | 1022 | 0.040 |
Why?
|
| Heredity | 1 | 2018 | 29 | 0.040 |
Why?
|
| Aurora Kinase A | 1 | 2019 | 202 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 182 | 0.040 |
Why?
|
| Wound Healing | 1 | 2023 | 815 | 0.040 |
Why?
|
| Cell Survival | 2 | 2016 | 3045 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 2216 | 0.040 |
Why?
|
| Chromosomes | 1 | 2018 | 244 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1331 | 0.040 |
Why?
|
| Wilms Tumor | 1 | 2019 | 292 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 289 | 0.040 |
Why?
|
| Hippocampus | 1 | 2022 | 915 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 1489 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 94 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2016 | 5710 | 0.030 |
Why?
|
| X-linked Nuclear Protein | 1 | 2016 | 56 | 0.030 |
Why?
|
| Mitotane | 1 | 2015 | 39 | 0.030 |
Why?
|
| Sarcoma, Ewing | 1 | 2019 | 406 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 238 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 479 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2018 | 4078 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 29 | 0.030 |
Why?
|
| DNA | 1 | 2023 | 2693 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 622 | 0.030 |
Why?
|
| Brain | 2 | 2020 | 4113 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5319 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2015 | 223 | 0.030 |
Why?
|
| Aging | 1 | 2022 | 1582 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1987 | 0.030 |
Why?
|
| Microglia | 1 | 2015 | 164 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 342 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2016 | 434 | 0.030 |
Why?
|
| Anilides | 1 | 2015 | 268 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 2450 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2014 | 324 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 862 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 1390 | 0.030 |
Why?
|
| Telomere | 1 | 2016 | 505 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 210 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 4143 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 3443 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2019 | 929 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 5114 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2011 | 110 | 0.030 |
Why?
|
| CpG Islands | 1 | 2014 | 633 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2011 | 103 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 905 | 0.020 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 598 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2019 | 2295 | 0.020 |
Why?
|
| Cell Division | 1 | 2015 | 2489 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2010 | 47 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2010 | 71 | 0.020 |
Why?
|
| Adenoma | 1 | 2015 | 716 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 1879 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 2488 | 0.020 |
Why?
|
| S Phase | 1 | 2010 | 281 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 1960 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 1282 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 347 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2010 | 196 | 0.020 |
Why?
|
| Proteome | 1 | 2013 | 561 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 508 | 0.020 |
Why?
|
| Survivors | 1 | 2015 | 1031 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 3719 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 1546 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 11538 | 0.020 |
Why?
|
| DNA Probes | 1 | 2008 | 217 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 1399 | 0.020 |
Why?
|
| Pyridines | 1 | 2015 | 1244 | 0.020 |
Why?
|
| Nucleotides | 1 | 2008 | 164 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 1547 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2011 | 629 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 287 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2011 | 747 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5637 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2008 | 247 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 328 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 2483 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 2961 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 3254 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 844 | 0.020 |
Why?
|
| Asthma | 1 | 2015 | 871 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 1385 | 0.020 |
Why?
|
| DNA Replication | 1 | 2010 | 744 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 4988 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 2927 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 2944 | 0.020 |
Why?
|
| Peptides | 1 | 2011 | 1479 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 1183 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6207 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 5377 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 2074 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2330 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 12873 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2008 | 1113 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 3869 | 0.020 |
Why?
|
| Breast | 1 | 2011 | 1344 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 7702 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12221 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 1529 | 0.010 |
Why?
|
| Chemoradiotherapy | 1 | 2011 | 1946 | 0.010 |
Why?
|
| Alleles | 1 | 2008 | 2437 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2015 | 9244 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 7789 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 14889 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4557 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 2027 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 15694 | 0.010 |
Why?
|